CAS 2102170-43-2

GNE-2256

Description:

As of my last update in October 2023, GNE-2256, with the CAS number 2102170-43-2, is a chemical compound that has been studied primarily in the context of pharmaceutical research. It is known to be a selective inhibitor of certain biological pathways, potentially offering therapeutic benefits in specific medical conditions. The compound's characteristics include its molecular structure, which is designed to interact with specific targets in biological systems, and its pharmacokinetic properties, which influence its absorption, distribution, metabolism, and excretion in the body. Additionally, GNE-2256 may exhibit specific solubility and stability profiles that are critical for its efficacy and safety in clinical applications. However, detailed information regarding its toxicity, side effects, and comprehensive mechanism of action may still be under investigation, as is common with many novel compounds in drug development. For the most accurate and up-to-date information, consulting scientific literature or databases is recommended.

Formula: C₂₄H₂₇FN₆O₄

Synonyms:

• GNE-2256
• Pyrazolo[1,5-a]pyrimidine-3-carboxamide, N-[2-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-2,3-dihydro-6-(4-morpholinyl)-1-oxo-1H-isoindol-5-yl]-

GNE-2256

CAS: 2102170-43-2

GNE-2256, also known as molecule 19, is an orally active compound that inhibits Interleukin 1 receptor-associated kinase 4 (IRAK4) with a K i of 1.4 nM and has

Formula: C₂₄H₂₇FN₆O₄

Color and Shape: Solid

Molecular weight: 482.51

Ref: TM-T73372